Potassium Ion

Potassium Ion

SCHEMBL22426233

CCCCB(CCCC)CCCC.[H-].[K+]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ANPEP P15144 1/20 0.47
▸ TSHR P16473 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ THRB P10828 1/20 0.38
▸ PCSK9 Q8NBP7 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ OPRM1 P35372 1/20 0.30
▸ SLC22A1 O15245 2/20 0.30
▸ SLC22A2 O15244 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL22426275 0.93 ANPEP (0.47) ANPEPTSHRLMNATHRBPCSK9
SCHEMBL1237 0.93 ANPEP (0.53) ANPEPTSHRLMNATHRBPCSK9
SCHEMBL10899969 0.93 ANPEP (0.53) ANPEPTSHRLMNATHRBPCSK9
SCHEMBL3887127 0.89 ANPEP (0.50) ANPEPTSHRLMNATHRBPCSK9
SCHEMBL51210 0.89 ANPEP (0.50) ANPEPTSHRLMNATHRBPCSK9
SCHEMBL9814415 0.89 ANPEP (0.50) ANPEPTSHRLMNATHRBPCSK9
SCHEMBL952691 0.89 ANPEP (0.50) ANPEPTSHRLMNATHRBPCSK9
Ammonia Solution, Strong SCHEMBL28825800 0.89 ANPEP (0.50) ANPEPTSHRLMNATHRBPCSK9
SCHEMBL88650 0.81 TSHR (0.50) ANPEPTSHRLMNATHRBALDH1A1
SCHEMBL11524980 0.81 TSHR (0.50) ANPEPTSHRLMNATHRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3597630-B1 DISSIMILAR-METAL SALT ASSEMBLY WHICH IS DENDRIMER HAVING FOUR OR MORE TYPES OF DISSIMILAR-METAL SALT COMPOUNDS PRECISELY INTEGRATED THEREIN, AND PRODUCTION METHOD FOR SUBNANO METAL PARTICLES TOKYO INST TECH (JP) 2021-09-15 — — EP disclosed
US-10781290-B2 Multiple metal salt assembly of dendrimer having four or more types of multiple-metal salt compound precisely assembled, and method for producing subnano metal particles TOKYO INSTITUTE OF TECHNOLOGY (JP) 2020-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10781290-B2 Multiple metal salt assembly of dendrimer having four or more types of multiple-metal salt compound precisely assembled, and method for producing subnano metal particles PICALM, SIN3A, KCNN3 ANPEP 1517/4885TSHR 2778/4885LMNA 3135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback